8-K: Momentus Secures $3.74M, Issues New Warrants

Momentus Inc. has entered into a warrant inducement agreement, generating approximately $3.74 million in gross proceeds by lowering the exercise price of existing warrants and issuing new warrants.

Summary

• Momentus Inc. entered into a warrant inducement agreement on December 9, 2025, with a holder of existing warrants.
• The holder exercised 4,862,058 existing warrants for cash at a reduced exercise price of $0.77 per share, generating approximately $3.74 million in gross proceeds.
• The original exercise price for these existing warrants was $1.11 per share.
• In consideration for the exercise, Momentus agreed to issue new warrants (Inducement Warrants) to purchase up to 7,293,087 shares of Common Stock, which is 150% of the number of shares exercised.
• The new warrants have an exercise price of $0.77 per share and will be exercisable on or after the Stockholder Approval Date, expiring five years from that date.
• The company also agreed to reduce the exercise price of certain other existing warrants, covering up to 7,469,607 shares, from $1.43 per share to $0.77 per share, subject to stockholder approval.
• If stockholder approval for the price reduction of these 7,469,607 warrants is not obtained within six months, their exercise price will automatically reduce to the Nasdaq Minimum Price, and they will expire five years from that date.
• Momentus engaged A.G.P./Alliance Global Partners as its financial advisor, incurring fees of approximately $262,060 plus up to $35,000 for legal expenses.
• The net proceeds from this transaction are expected to be used for general corporate purposes.

Sentiment

Score: 5

Explanation: The transaction provides immediate capital and addresses outstanding litigation, which are positive. However, it comes with significant potential for shareholder dilution and highlights a history of non-compliance with SEC filings, which are negatives. The overall sentiment is neutral to slightly negative due to the dilution and compliance issues offsetting the capital raise.

Positives

• Generated approximately $3.74 million in gross proceeds, providing immediate capital for the company.
• The capital raised is intended for general corporate purposes and to settle outstanding litigation, which could improve financial stability.
• The inducement offer successfully encouraged the exercise of existing warrants by reducing their exercise price, converting potential future capital into immediate cash.

Negatives

• The transaction involves significant potential for dilution of existing shareholders due to the issuance of up to 7,293,087 new warrants and the repricing of an additional 7,469,607 existing warrants, all at a low exercise price of $0.77.
• Incurred financial advisory fees of approximately $262,060 and legal expenses up to $35,000, reducing net proceeds.
• Requires stockholder approval for the issuance of new warrants and the reduction of the exercise price for other existing warrants, introducing a contingency and potential delay.
• The company has a history of failing to timely file several SEC reports, including 10-Qs, a 10-K, and 8-Ks, indicating potential compliance issues.

Risks

• Failure to obtain required stockholder approval for the issuance of new warrants and the reduction of the exercise price for other existing warrants could impact the full realization of the capital-raising strategy.
• Significant potential for dilution of existing shareholders due to the large number of new warrants issued and the reduced exercise price of other warrants, which could depress share price.
• The company's past failures to timely file SEC reports (10-Qs for March 31, 2024, June 30, 2024, and September 30, 2025; 10-K for December 31, 2023; and 8-Ks on October 24, 2024, and March 27, 2025) pose regulatory compliance risks and could affect investor confidence.
• The company is subject to restrictions on issuing certain equity securities or entering into Variable Rate Transactions for specified periods (30 to 90 days), which could limit future financing flexibility.
• The company faces outstanding litigation, which the proceeds are intended to settle, indicating ongoing legal exposure.

Future Outlook

The company expects to use the net proceeds from this transaction for general corporate purposes and to settle outstanding litigation. It plans to file a registration statement for the resale of the new warrant shares within 30 days of December 9, 2025, and aims for it to become effective within 60-90 days. Stockholder approval is required for the new warrants and the reduced exercise price of certain other existing warrants, with meetings to be held until approval is obtained or warrants are no longer outstanding.

Management Comments

• The Company expects to use the net proceeds from this transaction for general corporate purposes.

Industry Context

This transaction reflects a common strategy for companies, particularly those in capital-intensive sectors like space technology, to raise capital and manage their balance sheets. The inducement offer, involving a reduced exercise price and issuance of new warrants, is a mechanism to encourage existing warrant holders to convert, providing immediate cash flow. The need for stockholder approval for certain aspects of the transaction, as per Nasdaq rules, highlights the regulatory environment for such capital-raising activities.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• Holder consents to the use of proceeds from the exercise of existing warrants to settle outstanding litigation.
• The company will indemnify holder parties against losses related to actions instituted by stockholders not affiliated with the holder, or related to untrue statements/omissions in registration statements, except for information provided by the holder or fraud/gross negligence by the holder.

Stakeholder Impact

• Shareholders: Potential for significant dilution due to the issuance of new warrants and the reduced exercise price of existing warrants. The capital raise provides funds for operations and litigation settlement, which could stabilize the company.
• Warrant Holders: Benefited from a reduced exercise price for existing warrants and received new warrants, providing an incentive for immediate exercise and potential future gains.
• Creditors: Proceeds used for general corporate purposes and litigation settlement could improve the company's financial stability and ability to meet obligations.
• Management: Successfully executed a capital-raising strategy, but faces the task of obtaining stockholder approval and addressing past SEC filing deficiencies.

Next Steps

• File a registration statement on Form S-1 for the resale of the new warrant shares within 30 calendar days of December 9, 2025.
• Use commercially reasonable efforts to cause the resale registration statement to become effective within 60 calendar days (or 90 days if reviewed by the Commission).
• Hold an annual or special meeting of stockholders on or prior to 60 days following December 9, 2025, to obtain Stockholder Approval for the new warrants and the reduced exercise price of other existing warrants.
• If Stockholder Approval is not obtained at the first meeting, call a meeting every 30 days thereafter to seek Stockholder Approval until approval is obtained or the new warrants are no longer outstanding.

Key Dates

Recommendation

While the capital raise provides immediate liquidity and addresses outstanding litigation, the significant potential for dilution from both the new inducement warrants and the repriced existing warrants creates downward pressure on per-share value. The company's history of non-compliance with SEC filing deadlines also introduces regulatory risk and uncertainty. Investors should hold to monitor the impact of dilution, the successful resolution of litigation, and the company's ability to achieve future compliance and operational milestones before considering further investment.

Keywords

Momentus Inc., MNTS, Warrant Inducement, Capital Raise, Equity Financing, Dilution, Stockholder Approval, SEC Compliance, Space Industry, Financial Advisory